Novavax

NVAX

NVAX
Novavax Stock Quote
$97.07 $0.77 0.8%
Price as of July 10, 2020, 10:32 a.m. EDT View Interactive NVAX Charts

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Interactive Chart


News & Analysis: Novavax

The Fool has written over 300 articles on Novavax.

All

Market Moves

Podcasts

Earnings






Is There a Coronavirus Vaccine Yet?

Companies are testing COVID-19 vaccines right now -- if all goes smoothly, more than one may get to market at “warp speed.”